Sarah W. Harcum of Clemson University is leading a team that has received $6 million for research that could help lower the cost of several drugs that run into the thousands of dollars per treatment and fight some of the world’s most debilitating ailments.
Harcum is the principal investigator on the grant, and she is collaborating with researchers from the University of Delaware, Tulane University and Delaware State University. They are calling the project “Advanced Biomanufacturing: Catalyzing Improved Host Development and High Quality Medicines through Genome to Phenome Predictions.”
Co-principal investigators are Kelvin H. Lee, the Gore Professor of Chemical Engineering at the University of Delaware, and Anne S. Robinson, chair of the chemical and biomolecular engineering department at Tulane University.
